Forecast the future of neurology across 31+ indications
DRG Disease Landscape & Forecast
Clarivate Disease Landscape & Forecast reports offer expert-driven, patient-based insights to support confident decision-making across the Central Nervous System (CNS) pipeline.
Each report covers more than 31+ neurology indications and provides in-depth forecasting, clinical development analysis, and strategic market context tailored to the needs of pharmaceutical companies, biotech innovators, and investors.
Request more information
What’s included in the reports?
- Forecasts through 2033
Patient-based 10-year market outlooks by indication - Indication-specific strategy insights
Treatment trends, access and reimbursement, market dynamics, and more - Late-phase pipeline intelligence
Stay ahead of competitors with coverage of Phase IIb/III assets and timelines - Expert commentary
Interpret the data with clarity, thanks to our expert neurology analyst team including therapy area experts and neurologists.
Tailored to your needs
Whether you need insight into a single neurology disease or want a bundled view to guide portfolio planning, we’ve got you covered.
Connect with our team to explore the right options for your pipeline and commercial goals.
